PDB 5nw2
PDB Information
PDB | 5NW2 |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli |
Gene Source | Homo sapiens |
Primary Citation | Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).
J. Med. Chem.
|
Header | Ligase |
Released | 2017-05-04 |
Resolution | 2.200 |
CATH Insert Date | 14 Nov, 2017 |
PDB Images (29)
PDB Prints
PDB Chains (12)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 14 Nov, 2017 | Chopped |
B | 14 Nov, 2017 | Chopped |
C | 14 Nov, 2017 | Chopped |
D | 14 Nov, 2017 | Chopped |
E | 14 Nov, 2017 | Chopped |
F | 14 Nov, 2017 | Chopped |
G | 14 Nov, 2017 | Chopped |
H | 14 Nov, 2017 | Chopped |
I | 14 Nov, 2017 | Chopped |
J | 14 Nov, 2017 | Chopped |
K | 14 Nov, 2017 | Chopped |
L | 14 Nov, 2017 | Chopped |
CATH Domains (16)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
5nw2A00 | 10 Dec, 2017 | 3.10.20.90 | Assigned |
5nw2B00 | 10 Dec, 2017 | 3.30.710.10 | Assigned |
5nw2C01 | 10 Dec, 2017 | 2.60.40.780 | Assigned |
5nw2C02 | 10 Dec, 2017 | 1.10.750.10 | Assigned |
5nw2D00 | 10 Dec, 2017 | 3.10.20.90 | Assigned |
5nw2E00 | 10 Dec, 2017 | 3.30.710.10 | Assigned |
5nw2F01 | 10 Dec, 2017 | 2.60.40.780 | Assigned |
5nw2F02 | 10 Dec, 2017 | 1.10.750.10 | Assigned |
5nw2G00 | 10 Dec, 2017 | 3.10.20.90 | Assigned |
5nw2H00 | 10 Dec, 2017 | 3.30.710.10 | Assigned |
5nw2I01 | 10 Dec, 2017 | 2.60.40.780 | Assigned |
5nw2I02 | 10 Dec, 2017 | 1.10.750.10 | Assigned |
5nw2J00 | 10 Dec, 2017 | 3.10.20.90 | Assigned |
5nw2K00 | 10 Dec, 2017 | 3.30.710.10 | Assigned |
5nw2L01 | 10 Dec, 2017 | 2.60.40.780 | Assigned |
5nw2L02 | 10 Dec, 2017 | 1.10.750.10 | Assigned |
UniProtKB Entries (12)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
Q15369 | ELOC_HUMAN | Homo sapiens | Elongin-C |
Q15369 | ELOC_HUMAN | Homo sapiens | Elongin-C |
P40337 | VHL_HUMAN | Homo sapiens | von Hippel-Lindau disease tumor suppressor |
Q15370 | ELOB_HUMAN | Homo sapiens | Elongin-B |
Q15370 | ELOB_HUMAN | Homo sapiens | Elongin-B |
Q15369 | ELOC_HUMAN | Homo sapiens | Elongin-C |
Q15370 | ELOB_HUMAN | Homo sapiens | Elongin-B |
P40337 | VHL_HUMAN | Homo sapiens | von Hippel-Lindau disease tumor suppressor |
P40337 | VHL_HUMAN | Homo sapiens | von Hippel-Lindau disease tumor suppressor |
P40337 | VHL_HUMAN | Homo sapiens | von Hippel-Lindau disease tumor suppressor |
Q15369 | ELOC_HUMAN | Homo sapiens | Elongin-C |
Q15370 | ELOB_HUMAN | Homo sapiens | Elongin-B |